Literature DB >> 25813392

Different profiles of notch signaling in cigarette smoke-induced pulmonary emphysema and bleomycin-induced pulmonary fibrosis.

Shi Li1, Xiaofei Hu, Zheng Wang, Meng Wu, Jinnong Zhang.   

Abstract

OBJECTIVE: Different profiles of Notch signaling mediate naive T cell differentiation which might be involved in pulmonary emphysema and fibrosis.
METHODS: C57BL/6 mice were randomized into cigarette smoke (CS) exposure, bleomycin (BLM) exposure, and two separate groups of control for sham exposure to CS or BLM. The paratracheal lymph nodes of the animals were analyzed by real-time PCR and immunohistochemistry. Morphometry of the lung parenchyma, measurement of the cytokines, and cytometry of the bronchoalveolar lavage fluid (BALF) were also done accordingly.
RESULTS: In comparison with controls, all Notch receptors and ligands were upregulated by chronic CS exposure, especially Notch3 and DLL1 (P < 0.01), and this was in line with emphysema-like morphology and Th1-biased inflammation. While Notch3 and DLL1 were downregulated by BLM exposure (P < 0.01), those was in line with fibrotic lung remodeling and Th2 polarization.
CONCLUSIONS: This founding implies that the CS exposure but not the BLM exposure is capable of initiating Notch signaling in lymphoid tissue of the lung, which is likely relevant to the pathogenesis of pulmonary emphysema. Unable to initiate the Th1 response or inhibit it may lead to Th2 polarization and aberrant repair.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813392     DOI: 10.1007/s00011-015-0816-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  46 in total

1.  Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure.

Authors:  Andrew Churg; Steven Zhou; Olena Preobrazhenska; Hsin Tai; Rona Wang; Joanne L Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

2.  Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.

Authors:  J H Harrison; J S Lazo
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

3.  Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis.

Authors:  Keiko Mitaka; Yasunari Miyazaki; Makito Yasui; Masashi Furuie; Shuji Miyake; Naohiko Inase; Yasuyuki Yoshizawa
Journal:  Int Arch Allergy Immunol       Date:  2010-09-21       Impact factor: 2.749

4.  Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis.

Authors:  N W Lukacs; C Hogaboam; S W Chensue; K Blease; S L Kunkel
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 5.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

6.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3.

Authors:  Dianhua Jiang; Jiurong Liang; Jennifer Hodge; Bao Lu; Zhou Zhu; Shuang Yu; Juan Fan; Yunfei Gao; Zhinan Yin; Robert Homer; Craig Gerard; Paul W Noble
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice.

Authors:  Tine Demoor; Ken R Bracke; Karim Y Vermaelen; Lisa Dupont; Guy F Joos; Guy G Brusselle
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Dynamic expression of tumor necrosis factor-alpha and vascular endothelial growth factor in rat model of pulmonary emphysema induced by smoke exposure.

Authors:  Jinnong Zhang; Ling Zheng; Ming Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

9.  Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease.

Authors:  Ann E Tilley; Ben-Gary Harvey; Adriana Heguy; Neil R Hackett; Rui Wang; Timothy P O'Connor; Ronald G Crystal
Journal:  Am J Respir Crit Care Med       Date:  2008-12-23       Impact factor: 21.405

10.  Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease.

Authors:  Bryan L Eppert; Brian W Wortham; Jennifer L Flury; Michael T Borchers
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

View more
  6 in total

1.  Pre-exposure to Aerosolized Polyvalent Bacterial Lysates Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice.

Authors:  Xiaoling Zhu; Shan Yuan; Xiaofang Zheng; Xiaorong Wang; Jinnong Zhang
Journal:  Inflammation       Date:  2022-03-05       Impact factor: 4.092

2.  Cigarette Smoke Activates NOTCH3 to Promote Goblet Cell Differentiation in Human Airway Epithelial Cells.

Authors:  Manish Bodas; Andrew R Moore; Bharathiraja Subramaniyan; Constantin Georgescu; Jonathan D Wren; Willard M Freeman; Brent R Brown; Jordan P Metcalf; Matthew S Walters
Journal:  Am J Respir Cell Mol Biol       Date:  2021-04       Impact factor: 6.914

Review 3.  Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment.

Authors:  Moez Ghumman; Dinesh Dhamecha; Andrea Gonsalves; Lauren Fortier; Parand Sorkhdini; Yang Zhou; Jyothi U Menon
Journal:  Eur J Pharm Biopharm       Date:  2021-04-18       Impact factor: 5.589

4.  Epigenome-wide association study of serum cotinine in current smokers reveals novel genetically driven loci.

Authors:  Richa Gupta; Jenny van Dongen; Yu Fu; Abdel Abdellaoui; Rachel F Tyndale; Vidya Velagapudi; Dorret I Boomsma; Tellervo Korhonen; Jaakko Kaprio; Anu Loukola; Miina Ollikainen
Journal:  Clin Epigenetics       Date:  2019-01-05       Impact factor: 6.551

5.  Spiperone Stimulates Regeneration in Pulmonary Endothelium Damaged by Cigarette Smoke and Lipopolysaccharide.

Authors:  Evgenii Skurikhin; Olga Pershina; Mariia Zhukova; Darius Widera; Edgar Pan; Angelina Pakhomova; Vyacheslav Krupin; Natalia Ermakova; Victoria Skurikhina; Lubov Sandrikina; Sergey Morozov; Aslan Kubatiev; Alexander Dygai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-30

6.  Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease.

Authors:  François M Carlier; Sébastien Dupasquier; Jérôme Ambroise; Bruno Detry; Marylène Lecocq; Charline Biétry-Claudet; Yassine Boukala; Jean-Luc Gala; Caroline Bouzin; Stijn E Verleden; Delphine Hoton; Sophie Gohy; Bertrand Bearzatto; Charles Pilette
Journal:  EBioMedicine       Date:  2020-10-10       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.